Logo.png
Hunter Syndrome Market to Register Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - Denali Therapeutics Inc., JCR Pharmaceuticals Co., Ltd., REGENXBIO Inc., Shire, Takeda
November 09, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hunter Syndrome Market to Register Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - Denali Therapeutics Inc., JCR...
DENALI LOGO FOR PRESS RELEASE.jpg
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
February 05, 2021 09:00 ET | Denali Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to...
DENALI LOGO FOR PRESS RELEASE.jpg
Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020 07:30 ET | Denali Therapeutics Inc.
After four weekly intravenous doses of DNL310, a 76% mean reduction in CSF GAG levels (heparan sulfate) from baseline was observed, with normal healthy levels being achieved in four of five...
DENALI LOGO FOR PRESS RELEASE.jpg
Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
October 15, 2020 08:00 ET | Denali Therapeutics Inc.
Proprietary and differentiated Transport Vehicle (TV) technology shows potential to solve the BBB challenge by delivering biotherapeutics to the brainNew preclinical data support the potential for...
FBI LOGO TM.png
Hunter Syndrome Treatment Market to Exhibit a CAGR of 6.0% by 2026; Rising Clinical Studies for Diabetes to Influence Growth, states Fortune Business Insights™
March 27, 2020 10:30 ET | Fortune Business Insights
Pune, March 27, 2020 (GLOBE NEWSWIRE) -- The global Hunter syndrome treatment market size is predicted to reach USD 1,118.4 million by 2026, exhibiting a CAGR of 6.0% during the forecast period. The...